Recent advances in functional mesoporous silica-based nanoplatforms for combinational photo-chemotherapy of cancer
Source abstract
Abstract
In recent years, research trend has gradually removed from a concentration on monotherapy to combination therapy for fighting cancer. Combination photo-chemotherapy, including photodynamic-chemotherapy, photothermal-chemotherapy, as well as photodynamic-photothermal-chemotherapy, has demonstrated the priorities to elevate cancer therapeutic efficacies and diminish undesired side effects through different mechanisms in cancer treatment. In this review, we summarize the most recent progress in designing mesoporous silica-based nanoplatforms for combination delivery of multiple therapeutic agents, and discuss the treatment outcome in cancer by combining photodynamic therapy (PDT) and/or photothermal therapy (PTT) with chemotherapy. Furthermore, we highlight the drawbacks and challenges of employing mesoporous silica-based combinational formulations for effective cancer photo-chemotherapy, which might provide new guidelines for development of photo-chemo combination cancer treatments.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Nanotechnology for multimodal synergistic cancer therapy10.1021/acs.chemrev.7b00258 ↗
2. Cancer statistics, 2017
3. Nanooncology: the future of cancer diagnosis and therapy, CA-Cancer
4. Effects of combined drug therapy on metastatic cancer of the testis10.1001/jama.1960.03030100059013 ↗
5. Combinational strategy for high-performance cancer chemotherapy10.1016/j.biomaterials.2018.04.027 ↗
6. Nanotechnology for cancer therapy based on chemotherapy10.3390/molecules23040826 ↗
7. Recent advances in nanomaterial-based synergistic combination cancer immunotherapy10.1039/C8CS00896E ↗
8. Metal-organic frameworks for multimodal bioimaging and synergistic cancer chemotherapy10.1016/j.ccr.2019.213022 ↗
9. Nanoscaled red blood cells facilitate breast cancer treatment by combining photothermal/photodynamic therapy and chemotherapy10.1016/j.biomaterials.2017.11.002 ↗
10. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc (II) phthalocyanine for combined chemotherapy and photodynamic therapy10.1016/j.jconrel.2018.04.030 ↗
11. Photothermally-amplified therapeutic liposomes for effective combination treatment of cancer10.1021/acsami.7b15996 ↗
12. Multistage targeting strategy using magnetic composite nanoparticles for synergism of photothermal therapy and chemotherapy10.1002/smll.201702994 ↗
13. Synthesis of cisplatin (IV) prodrug-tethered CuFeS2 nanoparticles in tumor-targeted chemotherapy and photothermal therapy10.1021/acsami.7b19640 ↗
14. Mesoporous silica nanoparticles for drug delivery and biosensing applications10.1002/adfm.200601191 ↗
15. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles
16. Mesoporous silica nanoparticles in biomedical applications10.1039/c1cs15246g ↗
17. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery10.1002/adma.201104763 ↗
18. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications10.1021/ar2000259 ↗
19. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer10.1016/j.actbio.2019.02.031 ↗
20. Advances in multicompartment mesoporous silica micro/nanoparticles for theranostic applications
21. Synthesis of pH-responsive biodegradable mesoporous silica-calcium phosphate hybrid nanoparticle as a high potential drug carrier10.1021/acsami.7b16787 ↗
22. Intracellular delivery of functional native antibodies under hypoxic conditions by using a biodegradable silica nanoquencher10.1002/anie.201705578 ↗
23. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality10.1016/j.biomaterials.2017.02.018 ↗
24. Tri-stimuli-responsive biodegradable theranostics for mild hyperthermia enhanced chemotherapy10.1016/j.biomaterials.2017.02.025 ↗
25. Yolk-shell structured mesoporous nanoparticles with thioether-bridged organosilica frameworks10.1021/cm502777e ↗
26. Photoresponsive bridged silsesquioxane nanoparticles with tunable morphology for light-triggered plasmid DNA delivery10.1021/acsami.5b07365 ↗
27. Core-shell hierarchical mesostructured silica nanoparticles for gene/chemo-synergetic stepwise therapy of multidrug-resistant cancer10.1016/j.biomaterials.2017.04.028 ↗
28. Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer10.1080/17425247.2016.1211637 ↗
29. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT10.1016/j.jphotobiol.2009.04.001 ↗
30. Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment10.1002/ijc.31717 ↗
31. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy10.1111/j.1751-1097.2009.00585.x ↗
32. Glycosylated porphyrins, phthalocyanines, and other porphyrinoids for diagnostics and therapeutics10.1021/acs.chemrev.5b00244 ↗
33. Non-porphyrinoid photosensitizers mediated photodynamic inactivation against bacteria
34. The role of porphyrin chemistry in tumor imaging and photodynamic therapy
35. Supramolecular self-assembled nanoparticles for chemo-photodynamic dual therapy against cisplatin resistant cancer cells10.1039/C4CC08583C ↗
36. A reactive oxygen species (ROS)-responsive low molecular weight gel co-loaded with doxorubicin and Zn(II) phthalocyanine tetrasulfonic acid for combined chemo-photodynamic therapy10.1039/C7TB02359F ↗
37. MRI-guided tumor chemo-photodynamic therapy with Gd/Pt bifunctionalized porphyrin10.1039/C7BM00431A ↗
38. Dual pH-responsive mesoporous silica nanoparticles for efficient combination of chemotherapy and photodynamic therapy10.1039/C5TB00256G ↗
39. Modulation of hypoxia in solid tumor microenvironment with MnO2 nanoparticles to enhance photodynamic therapy10.1002/adfm.201600676 ↗
40. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion
41. Mesoporous silica-based versatile theranostic nanoplatform constructed by layer-by-layer assembly for excellent photodynamic/chemo therapy10.1016/j.biomaterials.2016.11.057 ↗
42. Recent advances in upconversion nanoparticles-based multifunctional nanocomposites for combined cancer therapy
43. Functional hollow nanostructures for imaging and phototherapy of tumor10.1039/C7TB02381B ↗
44. Recent progress in near infrared light triggered photodynamic therapy10.1002/smll.201702299 ↗
45. Photodynamic-based therapeutic modalities to fight against cancer-A review from synergistic viewpoint10.1016/j.jddst.2019.02.014 ↗
46. Silica coated upconversion nanoparticles: a versatile platform for the development of efficient theranostics10.1021/acs.accounts.5b00078 ↗
47. A smart upconversion-based mesoporous silica nanotheranostic system for synergetic chemo-/radio-/photodynamic therapy and simultaneous MR/UCL imaging10.1016/j.biomaterials.2014.07.024 ↗
48. Aromatic pathways of porphins, chlorins, and bacteriochlorins10.1021/jo300182b ↗
49. Supramolecular photosensitizers rejuvenate photodynamic therapy10.1039/C7CS00594F ↗
50. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy10.1016/j.apsb.2017.09.003 ↗
51. Co-delivery of cisplatin prodrug and chlorin e6 by mesoporous silica nanoparticles for chemo-photodynamic combination therapy to combat drug resistance10.1021/acsami.6b03881 ↗
52. Mesoporous silica nanorods intrinsically doped with photosensitizers as a multifunctional drug carrier for combination therapy of cancer10.1007/s12274-014-0558-0 ↗
53. Magnetic mesoporous silica nanoparticles coated with thermo-responsive copolymer for potential chemo- and magnetic hyperthermia therapy10.1016/j.micromeso.2017.07.053 ↗
54. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro10.1016/j.ejpb.2008.08.017 ↗
55. Ultrasound responsive mesoporous silica nanoparticles for biomedical applications10.1039/C8CC09389J ↗
56. Inhibition of multidrug resistance of cancer cells by co-delivery of DNA nanostructures and drugs using porous silicon nanoparticles@giant liposomes10.1002/adfm.201500594 ↗
57. Mesoporous silica-coated gold nanoframes as drug delivery system for remotely controllable chemo-photothermal combination therapy10.1016/j.colsurfb.2019.01.005 ↗
58. A step-by-step multiple stimuli-responsive nanoplatform for enhancing combined chemo-photodynamic therapy10.1002/adma.201605357 ↗
59. Functionalization of mesoporous silica nanoparticles for targeting, biocompatibility, combined cancer therapies and theragnosis10.1166/jnn.2013.7363 ↗
60. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles10.1002/adma.201205292 ↗
61. pH-responsive magnetic mesoporous silica-based nanoplatform for synergistic photodynamic therapy/chemotherapy10.1021/acsami.7b19797 ↗
62. Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites10.1039/C7BM00043J ↗
63. Enhanced blood suspensibility and laser-activated tumor-specific drug release of theranostic mesoporous silica nanoparticles by functionalizing with erythrocyte membranes10.7150/thno.17259 ↗
64. ROS-responsive mesoporous silica nanoparticles for MR imaging-guided photodynamically maneuvered chemotherapy10.1039/C8NR00888D ↗
65. Stimuli responsive phthalocyanine-based fluorescent probes and photosensitizers10.1016/j.ccr.2017.10.006 ↗
66. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy10.1016/j.ejmech.2018.03.077 ↗
67. A H2O2-responsive boron dipyrromethene-based photosensitizer for imaging-guided photodynamic therapy10.3390/molecules24010032 ↗
68. A pH-responsive fluorescence probe and photosensitiser based on a tetraamino silicon (IV) phthalocyanine10.1039/c000605j ↗
69. Triple-functional core-shell structured upconversion luminescent nanoparticles covalently grafted with photosensitizer for luminescent, magnetic resonance imaging and photodynamic therapy in vitro10.1039/c2nr30938f ↗
70. Mesoporous silica nanoparticles loaded with cisplatin and phthalocyanine for combination chemotherapy and photodynamic therapy in vitro10.3390/nano5042302 ↗
71. Novel core-interlayer-shell DOX/ZnPc co-loaded MSNs@pH-sensitive CaP@PEGylated liposome for enhanced synergetic chemo-photodynamic therapy10.1007/s11095-017-2295-z ↗
72. Encapsulating pH-responsive doxorubicin-phthalocyanine conjugates in mesoporous silica nanoparticles for combined photodynamic therapy and controlled chemotherapy10.1002/chem.201703188 ↗
73. Core-interlayer-shell Fe3O4 @mSiO2@lipid-PEG-methotrexate nanoparticle for multimodal imaging and multistage targeted chemo-photodynamic therapy10.1016/j.ijpharm.2017.01.068 ↗
74. Hypoxia induced by upconversion-based photodynamic therapy: towards highly effective synergistic bioreductive therapy in tumors10.1002/ange.201500478 ↗
75. Developments in PDT sensitizers for increased selectivity and singlet oxygen production10.3390/ma8074421 ↗
76. pH-Sensitive mesoporous silica nanoparticles for chemo-photodynamic combination therapy10.1016/j.colsurfb.2017.11.006 ↗
77. A multifunctional nanoplatform based on mesoporous silica nanoparticles for imaging-guided chemo/photodynamic synergetic therapy10.1039/C7RA04549B ↗
78. A size‐reducible nanodrug with an aggregation‐enhanced photodynamic effect for deep chemo‐photodynamic therapy10.1002/anie.201807602 ↗
79. Controlled co-release of doxorubicin and reactive oxygen species for synergistic therapy by NIR remote-triggered nanoimpellers10.1016/j.msec.2017.02.016 ↗
80. NIR light-activated dual-modality cancer therapy mediated by photochemical internalization of porous nanocarriers with tethered lipid bilayer10.1039/C7TB02095C ↗
81. Self-decomposable mesoporous doxorubicin@silica nanocomposites for nuclear targeted chemo-photodynamic combination therapy10.1021/acsanm.8b00486 ↗
82. Nanomaterials as photothermal therapeutic agents10.1016/j.pmatsci.2018.07.005 ↗
83. Recent advances in nanomaterials for enhanced photothermal therapy of tumors10.1039/C8NR07627H ↗
84. Organic molecule-based photothermal agents: an expanding photothermal therapy universe10.1039/C7CS00522A ↗
85. Combined hyperthermia and chemotherapy as a synergistic anticancer treatment
86. “Smart” materials-based near-infrared light-responsive drug delivery systems for cancer treatment: a review10.1016/j.jmrt.2018.03.007 ↗
87. Multifunctional mesoporous silica nanoparticles with thermal-responsive gatekeeper for nir light-triggered chemo/photothermal-therapy10.1002/smll.201601137 ↗
88. Thermo/pH dual-stimuli-responsive drug delivery for chemo-/photothermal therapy monitored by cell imaging10.1016/j.talanta.2018.01.018 ↗
89. A multifunctional biodegradable nanocomposite for cancer theranostics10.1002/advs.201802001 ↗
90. Constructing reduction-sensitive PEGylated NIRF mesoporous silica nanoparticles via a one-pot Passerini reaction for photothermal/chemo-therapy10.1039/C8CC07106C ↗
91. Prussian blue decorated mesoporous silica hybrid nanocarriers for photoacoustic imaging-guided synergistic chemo-photothermal combination therapy10.1039/C8TB01214H ↗
92. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer10.1016/j.actbio.2017.01.015 ↗
93. Biodegradable luminescent porous silicon nanoparticles for in vivo applications10.1038/nmat2398 ↗
94. Biodegradable silicon nanoneedles delivering nucleic acids intracellularly induce localized in vivo neovascularization10.1038/nmat4249 ↗
95. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats10.1021/nn901657w ↗
96. Near-infrared light-responsive inorganic nanomaterials for photothermal therapy
97. Silica-based organic-inorganic hybrid nanoparticles and nanoconjugates for improved anticancer drug delivery10.1002/elsc.201800038 ↗
98. Gold nanocages as photothermal transducers for cancer treatment10.1002/smll.200902216 ↗
99. Gold nanostructures: a class of multifunctional materials for biomedical applications10.1039/B821763G ↗
100. Gold nanostructures as a platform for combinational therapy in future cancer therapeutics10.3390/cancers3011081 ↗